$AOSL
ALPHA & OMEGA SEMICONDUCTOR Ltd Stock $aosl

$aosl Overview Financials Valuation SEC Filings Company Website

2015 Q2 Form 10-Q Financial Statement

#000138746715000054 Filed on May 07, 2015

Income Statement

Concept	2015 Q2	2015 Q1	2014 Q2
Revenue	$81.50M	$76.92M	$82.30M
YoY Change	-0.97%	2.01%	6.61%
Cost Of Revenue	$67.20M	$64.15M	$66.30M
YoY Change	1.36%	1.68%	3.59%
Gross Profit	$14.30M	$12.76M	$16.00M
YoY Change	-10.63%	3.69%	21.21%
Gross Profit Margin	17.55%	16.59%	19.44%
Selling, General & Admin	$9.700M	$9.219M	$9.000M
YoY Change	7.78%	-0.4%	1.12%
% of Gross Profit	67.83%	72.23%	56.25%
Research & Development	$6.900M	$6.929M	$6.600M
YoY Change	4.55%	15.93%	-8.33%
% of Gross Profit	48.25%	54.29%	41.25%
Depreciation & Amortization	$6.880M	$6.760M	$7.300M
YoY Change	-5.75%	-2.17%	3.4%
% of Gross Profit	48.11%	52.96%	45.63%
Operating Expenses	$16.50M	$16.15M	$15.70M
YoY Change	5.1%	6.01%	-2.48%
Operating Profit	-$2.200M	-$3.384M	$300.0K
YoY Change	-833.33%	15.77%	-110.34%
Interest Expense	$400.0K	$41.00K	-$300.0K
YoY Change	-233.33%	-33.87%	200.0%
% of Operating Profit			-100.0%
Other Income/Expense, Net
YoY Change
Pretax Income	-$1.900M	-$3.407M	$0.00
YoY Change		16.16%	-100.0%
Income Tax	$1.100M	$698.0K	$300.0K
% Of Pretax Income
Net Earnings	-$2.900M	-$4.105M	-$300.0K
YoY Change	866.67%	24.62%	-92.68%
Net Earnings / Revenue	-3.56%	-5.34%	-0.36%
Basic Earnings Per Share		-$0.16
Diluted Earnings Per Share	-$110.3K	-$0.16	-$11.45K
COMMON SHARES
Basic Shares Outstanding	26.34M shares	26.45M shares	26.13M shares
Diluted Shares Outstanding		26.45M shares

Balance Sheet

Concept	2015 Q2	2015 Q1	2014 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$106.1M	$112.9M	$117.8M
YoY Change	-9.93%	2.08%	27.49%
Cash & Equivalents	$106.1M	$112.9M	$117.8M
Short-Term Investments
Other Short-Term Assets	$4.279M	$3.433M	$3.810M
YoY Change	12.31%	-8.11%	6.48%
Inventory	$64.18M	$66.31M	$66.56M
Prepaid Expenses
Receivables	$38.78M	$31.14M	$36.54M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$213.7M	$217.0M	$227.8M
YoY Change	-6.19%	1.77%	10.65%
LONG-TERM ASSETS
Property, Plant & Equipment	$119.6M	$115.8M	$123.3M
YoY Change	-2.98%	-6.36%	-10.76%
Goodwill	$269.0K	$269.0K	$269.0K
YoY Change	0.0%	0.0%	0.0%
Intangibles	$17.00K		$229.0K
YoY Change	-92.58%		-53.83%
Long-Term Investments	$100.0K	$100.0K	$100.0K
YoY Change	0.0%	0.0%	0.0%
Other Assets	$2.297M	$3.281M	$1.963M
YoY Change	17.01%	102.78%	155.93%
Total Long-Term Assets	$134.2M	$130.3M	$136.6M
YoY Change	-1.72%	-4.55%	-9.24%
TOTAL ASSETS
Total Short-Term Assets	$213.7M	$217.0M	$227.8M
Total Long-Term Assets	$134.2M	$130.3M	$136.6M
Total Assets	$347.9M	$347.3M	$364.3M
YoY Change	-4.51%	-0.7%	2.25%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$44.08M	$34.40M	$38.76M
YoY Change	13.73%	23.07%	22.12%
Accrued Expenses	$19.23M	$17.68M	$17.38M
YoY Change	10.64%	4.52%	19.25%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00	$6.429M	$13.82M
YoY Change	-100.0%	106.92%	261.71%
Total Short-Term Liabilities	$66.34M	$62.00M	$73.62M
YoY Change	-9.89%	22.27%	37.62%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$300.0K	$0.00
YoY Change		-97.38%	-100.0%
Other Long-Term Liabilities	$1.017M	$1.004M	$1.143M
YoY Change	-11.02%	-72.11%	-77.14%
Total Long-Term Liabilities	$1.017M	$1.004M	$1.143M
YoY Change	-11.02%	-91.22%	-91.58%
TOTAL LIABILITIES
Total Short-Term Liabilities	$66.34M	$62.00M	$73.62M
Total Long-Term Liabilities	$1.017M	$1.004M	$1.143M
Total Liabilities	$71.27M	$68.47M	$81.31M
YoY Change	-12.36%	0.77%	8.61%
SHAREHOLDERS EQUITY
Retained Earnings	$103.2M	$105.8M	$110.8M
YoY Change	-6.79%	-4.88%	-2.97%
Common Stock	$55.00K	$54.00K	$53.00K
YoY Change	3.77%	1.89%	3.92%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$8.593M	$6.759M	$2.889M
YoY Change	197.44%	242.57%	40.65%
Treasury Stock Shares	998.0K shares	781.0K shares	340.0K shares
Shareholders Equity	$276.6M	$278.8M	$283.0M
YoY Change
Total Liabilities & Shareholders Equity	$347.9M	$347.3M	$364.3M
YoY Change	-4.51%	-0.7%	2.25%

Cashflow Statement

Concept	2015 Q2	2015 Q1	2014 Q2
OPERATING ACTIVITIES
Net Income	-$2.900M	-$4.105M	-$300.0K
YoY Change	866.67%	24.62%	-92.68%
Depreciation, Depletion And Amortization	$6.880M	$6.760M	$7.300M
YoY Change	-5.75%	-2.17%	3.4%
Cash From Operating Activities	$9.950M	$2.670M	$11.00M
YoY Change	-9.55%	-77.6%	-233.5%
INVESTING ACTIVITIES
Capital Expenditures	-$8.910M	-$5.640M	-$2.940M
YoY Change	203.06%	77.36%	-16.48%
Acquisitions
YoY Change
Other Investing Activities	$100.0K	$10.00K	-$50.00K
YoY Change	-300.0%	0.0%	-119.23%
Cash From Investing Activities	-$8.820M	-$5.630M	-$2.970M
YoY Change	196.97%	77.04%	-9.17%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-7.980M	-4.780M	-890.0K
YoY Change	796.63%	658.73%	641.67%
NET CHANGE
Cash From Operating Activities	9.950M	2.670M	11.00M
Cash From Investing Activities	-8.820M	-5.630M	-2.970M
Cash From Financing Activities	-7.980M	-4.780M	-890.0K
Net Change In Cash	-6.850M	-7.740M	7.140M
YoY Change	-195.94%	-195.44%	-161.39%
FREE CASH FLOW
Cash From Operating Activities	$9.950M	$2.670M	$11.00M
Capital Expenditures	-$8.910M	-$5.640M	-$2.940M
Free Cash Flow	$18.86M	$8.310M	$13.94M
YoY Change	35.29%	-44.97%	-395.34%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2014Q2	aosl	Accrued Facility Expenses AccruedFacilityExpenses	1353000	USD
CY2015Q1	aosl	Accrued Facility Expenses AccruedFacilityExpenses	1479000	USD
CY2014Q2	aosl	Accrued Inventory AccruedInventory	590000	USD
CY2015Q1	aosl	Accrued Inventory AccruedInventory	539000	USD
CY2014Q2	aosl	Allowance For Price Adjustments Receivable Current AllowanceForPriceAdjustmentsReceivableCurrent	14563000	USD
CY2015Q1	aosl	Allowance For Price Adjustments Receivable Current AllowanceForPriceAdjustmentsReceivableCurrent	17012000	USD
CY2014Q2	aosl	Deferred Revenue Net Of Deferred Costs Current DeferredRevenueNetOfDeferredCostsCurrent	665000	USD
CY2015Q1	aosl	Deferred Revenue Net Of Deferred Costs Current DeferredRevenueNetOfDeferredCostsCurrent	699000	USD
CY2014Q2	aosl	Employee Stock Purchase Plan Payable Current EmployeeStockPurchasePlanPayableCurrent	323000	USD
CY2015Q1	aosl	Employee Stock Purchase Plan Payable Current EmployeeStockPurchasePlanPayableCurrent	832000	USD
CY2014Q2	aosl	Prepayment For Property And Equipment PrepaymentForPropertyAndEquipment	1435000	USD
CY2015Q1	aosl	Prepayment For Property And Equipment PrepaymentForPropertyAndEquipment	2543000	USD
CY2014Q2	aosl	Property Plant And Equipment Excluding Equipment And Construction In Progress Gross PropertyPlantAndEquipmentExcludingEquipmentAndConstructionInProgressGross	227012000	USD
CY2015Q1	aosl	Property Plant And Equipment Excluding Equipment And Construction In Progress Gross PropertyPlantAndEquipmentExcludingEquipmentAndConstructionInProgressGross	239505000	USD
CY2014Q2	aosl	Property Plant And Equipment Excluding Equipment And Construction In Progress Net PropertyPlantAndEquipmentExcludingEquipmentAndConstructionInProgressNet	112354000	USD
CY2015Q1	aosl	Property Plant And Equipment Excluding Equipment And Construction In Progress Net PropertyPlantAndEquipmentExcludingEquipmentAndConstructionInProgressNet	104367000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	283000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	140000	USD
CY2013Q2	aosl	Stock Rotation Accrual Current StockRotationAccrualCurrent	1572000	USD
CY2014Q1	aosl	Stock Rotation Accrual Current StockRotationAccrualCurrent	2794000	USD
CY2014Q2	aosl	Stock Rotation Accrual Current StockRotationAccrualCurrent	1645000	USD
CY2015Q1	aosl	Stock Rotation Accrual Current StockRotationAccrualCurrent	1774000	USD
	aosl	Stock Rotation Accrual Payments StockRotationAccrualPayments	2480000	USD
	aosl	Stock Rotation Accrual Payments StockRotationAccrualPayments	4000000	USD
	aosl	Stock Rotation Accrual Stock Issued StockRotationAccrualStockIssued	3702000	USD
	aosl	Stock Rotation Accrual Stock Issued StockRotationAccrualStockIssued	4129000	USD
	aosl	Treasury Stock Reissued Average Price Per Share TreasuryStockReissuedAveragePricePerShare	2.22
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
	dei	Document Period End Date DocumentPeriodEndDate	2015-03-31
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001387467
CY2015Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	26343613	shares
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	ALPHA & OMEGA SEMICONDUCTOR Ltd
CY2014Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	38760000	USD
CY2015Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	34396000	USD
CY2014Q2	us-gaap	Accounts Receivable Gross AccountsReceivableGross	51128000	USD
CY2015Q1	us-gaap	Accounts Receivable Gross AccountsReceivableGross	48183000	USD
CY2014Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	36535000	USD
CY2015Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	31141000	USD
CY2014Q2	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	1873000	USD
CY2015Q1	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	1061000	USD
CY2014Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	1933000	USD
CY2015Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	1821000	USD
CY2014Q2	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	2315000	USD
CY2015Q1	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	1622000	USD
CY2014Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	17376000	USD
CY2015Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	17675000	USD
CY2014Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1001000	USD
CY2015Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	883000	USD
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	92000	USD
CY2014Q2	us-gaap	Accrued Vacation Current AccruedVacationCurrent	1777000	USD
CY2015Q1	us-gaap	Accrued Vacation Current AccruedVacationCurrent	1936000	USD
CY2014Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	114658000	USD
CY2015Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	135138000	USD
CY2014Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1033000	USD
CY2015Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	915000	USD
CY2014Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	174084000	USD
CY2015Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	178820000	USD
CY2014Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	861000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2175000	USD
CY2015Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	940000	USD
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-952000	USD
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-144000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3319000	USD
CY2014Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	30000	USD
CY2015Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	30000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-221000	USD
CY2014Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4199000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4516000	shares
CY2015Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3993000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4130000	shares
CY2014Q2	us-gaap	Assets Assets	364348000	USD
CY2015Q1	us-gaap	Assets Assets	347314000	USD
CY2014Q2	us-gaap	Assets Current AssetsCurrent	227779000	USD
CY2015Q1	us-gaap	Assets Current AssetsCurrent	216992000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1635000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	4137000	USD
CY2014Q2	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	1061000	USD
CY2015Q1	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	978000	USD
CY2014Q2	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	1005000	USD
CY2015Q1	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	299000	USD
CY2013Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	92406000	USD
CY2014Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	110634000	USD
CY2014Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	117788000	USD
CY2015Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	112931000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	18228000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-4857000	USD
CY2014Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.002
CY2015Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.002
CY2014Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2015Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2014Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	26644000	shares
CY2015Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	27090000	shares
CY2014Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	26304000	shares
CY2015Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	26309000	shares
CY2014Q2	us-gaap	Common Stock Value CommonStockValue	53000	USD
CY2015Q1	us-gaap	Common Stock Value CommonStockValue	54000	USD
CY2014Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3325000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2809000	USD
CY2015Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4077000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4956000	USD
CY2014Q2	us-gaap	Construction In Progress Gross ConstructionInProgressGross	10900000	USD
CY2015Q1	us-gaap	Construction In Progress Gross ConstructionInProgressGross	11450000	USD
CY2014Q2	us-gaap	Cost Method Investments CostMethodInvestments	100000	USD
CY2015Q1	us-gaap	Cost Method Investments CostMethodInvestments	100000	USD
CY2014Q1	us-gaap	Cost Of Goods Sold CostOfGoodsSold	63095000	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	192711000	USD
CY2015Q1	us-gaap	Cost Of Goods Sold CostOfGoodsSold	64154000	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	200297000	USD
CY2014Q2	us-gaap	Customer Deposits Current CustomerDepositsCurrent	104000	USD
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	120000	USD
CY2015Q1	us-gaap	Customer Deposits Current CustomerDepositsCurrent	73000	USD
	us-gaap	Debt Instrument Decrease Forgiveness DebtInstrumentDecreaseForgiveness	0	USD
CY2014Q3	us-gaap	Debt Instrument Decrease Forgiveness DebtInstrumentDecreaseForgiveness	250000	USD
	us-gaap	Debt Instrument Decrease Forgiveness DebtInstrumentDecreaseForgiveness	-250000	USD
CY2014Q2	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	1143000	USD
CY2015Q1	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	1004000	USD
CY2014Q2	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	2842000	USD
CY2015Q1	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	2931000	USD
CY2014Q2	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	10854000	USD
CY2015Q1	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	10938000	USD
CY2014Q2	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	3234000	USD
CY2015Q1	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	3551000	USD
	us-gaap	Depreciation Depreciation	20577000	USD
	us-gaap	Depreciation Depreciation	20666000	USD
CY2014Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
CY2015Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.16
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.18
CY2014Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.13
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.11
CY2015Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.16
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.18
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-11000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-49000	USD
CY2014Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.123
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-7.290
CY2015Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.205
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-1.405
CY2014Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4879000	USD
CY2015Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	5314000	USD
CY2015Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	5600000	USD
CY2015Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y9M18D
CY2014Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	229000	USD
CY2015Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	17000	USD
CY2014Q2	us-gaap	Goodwill Goodwill	269000	USD
CY2015Q1	us-gaap	Goodwill Goodwill	269000	USD
CY2014Q1	us-gaap	Gross Profit GrossProfit	12310000	USD
	us-gaap	Gross Profit GrossProfit	43080000	USD
CY2015Q1	us-gaap	Gross Profit GrossProfit	12764000	USD
	us-gaap	Gross Profit GrossProfit	46166000	USD
CY2014Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2933000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-341000	USD
CY2015Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3407000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2012000	USD
CY2015Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	698000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2826000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-3683000	USD
CY2014Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	361000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2486000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-5046000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1509000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-5605000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-1125000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-805000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	2053000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-431000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-8538000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-249000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	1008000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	939000	USD
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	-1000	USD
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	1000	USD
CY2014Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	52000	USD
	us-gaap	Interest And Other Income InterestAndOtherIncome	90000	USD
CY2015Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	18000	USD
	us-gaap	Interest And Other Income InterestAndOtherIncome	92000	USD
CY2014Q1	us-gaap	Interest Expense InterestExpense	62000	USD
	us-gaap	Interest Expense InterestExpense	210000	USD
CY2015Q1	us-gaap	Interest Expense InterestExpense	41000	USD
	us-gaap	Interest Expense InterestExpense	157000	USD
CY2014Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	11561000	USD
CY2015Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	12534000	USD
CY2014Q2	us-gaap	Inventory Net InventoryNet	66560000	USD
CY2015Q1	us-gaap	Inventory Net InventoryNet	66311000	USD
CY2014Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	18996000	USD
CY2015Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	20147000	USD
CY2014Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	36003000	USD
CY2015Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	33630000	USD
CY2014Q2	us-gaap	Liabilities Liabilities	81313000	USD
CY2015Q1	us-gaap	Liabilities Liabilities	68474000	USD
CY2014Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	364348000	USD
CY2015Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	347314000	USD
CY2014Q2	us-gaap	Liabilities Current LiabilitiesCurrent	73616000	USD
CY2015Q1	us-gaap	Liabilities Current LiabilitiesCurrent	61998000	USD
CY2014Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	13821000	USD
CY2015Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	6429000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2505000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-10000000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-6217000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-12530000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	26961000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	17722000	USD
CY2014Q1	us-gaap	Net Income Loss NetIncomeLoss	-3294000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-2827000	USD
CY2015Q1	us-gaap	Net Income Loss NetIncomeLoss	-4105000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-4838000	USD
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	Segment
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	Segment
CY2014Q1	us-gaap	Operating Expenses OperatingExpenses	15233000	USD
	us-gaap	Operating Expenses OperatingExpenses	43301000	USD
CY2015Q1	us-gaap	Operating Expenses OperatingExpenses	16148000	USD
	us-gaap	Operating Expenses OperatingExpenses	48113000	USD
CY2014Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2923000	USD
CY2015Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-3384000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1947000	USD
CY2014Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2485000	USD
CY2015Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2667000	USD
CY2014Q2	us-gaap	Other Assets Current OtherAssetsCurrent	3810000	USD
CY2015Q1	us-gaap	Other Assets Current OtherAssetsCurrent	3433000	USD
CY2014Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1963000	USD
CY2015Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3281000	USD
CY2014Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-31000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	18000	USD
CY2015Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	28000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-118000	USD
CY2014Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1143000	USD
CY2015Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1004000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	3977000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	6462000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	12579000	USD
CY2014Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.002
CY2015Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.002
CY2014Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2015Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2014Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2015Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2014Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2015Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2014Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2015Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	1279000	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	1910000	USD
	us-gaap	Proceeds From Sale Of Other Property Plant And Equipment ProceedsFromSaleOfOtherPropertyPlantAndEquipment	244000	USD
	us-gaap	Proceeds From Sale Of Other Property Plant And Equipment ProceedsFromSaleOfOtherPropertyPlantAndEquipment	50000	USD
CY2013Q2	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	1428000	USD
CY2014Q1	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	1181000	USD
CY2014Q2	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	1346000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	USD
CY2015Q1	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	1117000	USD
CY2014Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	123254000	USD
CY2015Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	115817000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-363000	USD
	us-gaap	Stock Issued During Period Value Treasury Stock Reissued StockIssuedDuringPeriodValueTreasuryStockReissued	83000	USD
	us-gaap	Stock Issued During Period Value Treasury Stock Reissued StockIssuedDuringPeriodValueTreasuryStockReissued	106000	USD
	us-gaap	Repayments Of Debt RepaymentsOfDebt	2857000	USD
	us-gaap	Repayments Of Debt RepaymentsOfDebt	7143000	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	927000	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	790000	USD
CY2014Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5977000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	17796000	USD
CY2015Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6929000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	20155000	USD
CY2014Q2	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	244000	USD
CY2015Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	245000	USD
CY2014Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	110754000	USD
CY2015Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	105810000	USD
CY2014Q1	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	75405000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	235791000	USD
CY2015Q1	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	76918000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	246463000	USD
CY2014Q2	us-gaap	Security Deposit SecurityDeposit	428000	USD
CY2015Q1	us-gaap	Security Deposit SecurityDeposit	638000	USD
CY2014Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	9256000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	25505000	USD
CY2015Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	9219000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	27958000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	2175000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	3319000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	740051	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	132085	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	10.19
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	10000	shares
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	3258607	USD
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1974804	USD
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3238784	shares
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2918634	shares
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	10.28
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	10.60
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	2860969	shares
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	10.65
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	5.70
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	9.07
CY2015Q1	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	2323289	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P4Y8M9D
CY2015Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	11.22
	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P4Y9M7D
	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	1186000	USD
	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	1445000	USD
	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	939000	USD
	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	1216000	USD
	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	29300	shares
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	198065	shares
CY2010Q4	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	25000000	USD
CY2015Q1	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	17800000	USD
CY2014Q2	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	22700000	USD
CY2014Q2	us-gaap	Stockholders Equity StockholdersEquity	283035000	USD
CY2015Q1	us-gaap	Stockholders Equity StockholdersEquity	278840000	USD
	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	8.84
	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	8.85
CY2014Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	340000	shares
CY2015Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	781000	shares
	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	810611	shares
	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	449247	shares
	us-gaap	Treasury Stock Shares Retired TreasuryStockSharesRetired	0	shares
CY2014Q2	us-gaap	Treasury Stock Value TreasuryStockValue	2889000	USD
CY2015Q1	us-gaap	Treasury Stock Value TreasuryStockValue	6759000	USD
	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	7200000	USD
	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	4000000	USD
CY2015Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	6300000	USD
CY2015Q1	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	4300000	USD
CY2014Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	26067000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25865000	shares
CY2015Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	26447000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	26469000	shares
CY2014Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	26067000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25865000	shares
CY2015Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	26447000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	26469000	shares
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company manages its credit risk associated with exposure to distributors and direct customers on outstanding accounts receivable through the application of credit approvals, credit ratings and other monitoring procedures. In some instances, the Company also obtains letters of credit from certain customers. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Credit sales, which are mainly on credit terms of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">30 to 60 days</font><font style="font-family:inherit;font-size:10pt;">, are only made to customers who meet the Company's credit requirements, while sales to new customers or customers with low credit ratings are usually made on an advance payment basis. The Company considers its trade accounts receivable to be of good credit quality because its key distributors and direct customers have long-standing business relationships with the Company and the Company has not experienced any significant bad debt write-offs of accounts receivable in the past. The Company closely monitors the aging of accounts receivable from its distributors and direct customers, and regularly reviews their financial positions, when available.</font></div></div>
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires the Company to make estimates, judgments and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses. To the extent there are material differences between these estimates and actual results, the Company's condensed consolidated financial statements will be affected. On an ongoing basis, the Company evaluates the estimates, judgments and assumptions including those related to stock rotation returns, price adjustments, allowance for doubtful accounts, inventory reserves, warranty accrual, income taxes, share-based compensation, and useful lives for property, plant and equipment and intangible assets.</font></div></div>

Files In Submission

Name	View Source	Status
0001387467-15-000054-index-headers.html	Edgar Link	pending
0001387467-15-000054-index.html	Edgar Link	pending
0001387467-15-000054.txt	Edgar Link	pending
0001387467-15-000054-xbrl.zip	Edgar Link	pending
aosl-20150331.xml	Edgar Link	completed
aosl-20150331.xsd	Edgar Link	pending
aosl-20150331_cal.xml	Edgar Link	unprocessable
aosl-20150331_def.xml	Edgar Link	unprocessable
aosl-20150331_lab.xml	Edgar Link	unprocessable
aosl-20150331_pre.xml	Edgar Link	unprocessable
aosl0331201510q.htm	Edgar Link	pending
ex311-aosl03312015q3201510q.htm	Edgar Link	pending
ex312-aosl03312015q3201510q.htm	Edgar Link	pending
ex321-aosl03312015q3201510q.htm	Edgar Link	pending
ex322-aosl03312015q3201510q.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AOSL
ALPHA & OMEGA SEMICONDUCTOR Ltd Stock $aosl

2015 Q2 Form 10-Q Financial Statement

#000138746715000054 Filed on May 07, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AOSL ALPHA & OMEGA SEMICONDUCTOR Ltd Stock $aosl

2015 Q2 Form 10-Q Financial Statement

#000138746715000054 Filed on May 07, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AOSL
ALPHA & OMEGA SEMICONDUCTOR Ltd Stock $aosl